Assessment of pleiotropic effects of nebivolol: influence on microcirculation parameters and bone tissue in postmenopausal women with mild arterial hypertension

Aim. To assess influence of nebivolol on microcirculation (MC) and mineral density of bones (MDB) in postmenopausal women with mild arterial hypertension (AH) and osteopenia.

Material and methods. To randomized controlled study were included 56 women of postmenopausal period at the age 50-65 y.o. with osteopenia and mild AH. During 12 months the main group (n=28) were taking nebivolol 2,5-5 mg, and controls (n=28) — atenolol 25-50 mg. At baseline and in 12 months clinical investigation was done, with anthropometry, blood pressure measurement, electrocardiogram registration, and qualitative MDB assessment via double energetic x-ray absorptiometry and assessment of MC with the application of computerized monochannel laser analyzer of capillary flow. In addition, we measured the levels of ionized calcium (Ca2+), total alkaline phosphatase (TAP), C-telopeptide of collagen I type (CTP).

Results. At the background of mild AH therapy with nebivolol during 12 months there was increase of MDB in the spine by T-criterium from -1,7±0,4SD to -1,4±0,53 (р<0,001), in femoral cervix (FC) from -1,4±0,44SD to -1,27±0,5SD (р=0,015), in proximal part of femur (PPF) from -0,58±0,4SD to -0,49±0,4SD (р=0,003), however in control group on atenolol there was decrease of MDB of the spine by T-criteria from -1,5±0,7SD to -1,6±0,64SD (p<0,001), in FC from -1,3±0,64SD to -1,5±0,65 (р=0,0005), MDB of PPF was stable (р=0,3). In the main group there was difference of MC value by 107,4±11,2% (р<0,001) and MC effectiveness index by 318±53% (р<0,001), in control group MC value decreased by 15,7±8,5% (р=0,07), decrease of MC effectiveness index was not significant. During therapy, there was decrease of CTP in serum by 17,7±2,6% (р<0,001), though in control group this parameter increased by 44,7±11,2% (р<0,001). Dynamics of MDB in all studied regions, of MC parameters, of CTP level on therapy during 12 months significantly differed between main and control groups.

Conclusion. In the study, we showed positive effect of nebivolol on MDB and MC.

1. Gandolini G, Grossi E, Bevilacqua M. Is the association between hypertension and bone osteoporotic fracture expressing a real interdependence? Diue from GISMO Lombardia database. J Bone Miner Res 2008; 23: S 329: Abstract SU 346.

2. Peres-Castrillon JL, De Luis D, Duenas-Laita A. Atherosclerosis and osteoporosis. Minerva Med. 2008; 99(1): 4-54.

3. Sennerby U, Farahmand B. Cardiovascular desease and future risk of hip fracture in women. Osteoporosis Int 2007; 18(10): 1355-62.

4. Makolkin VI, Podzolkov VI, Branko VV. Microcirculation in cardiology. M., 2004; 135p. Russian (Makolkin V.I., Podzolkov V.I., Bran'ko V.V. Mikrotsirkulyatsiya v kardiologii. M., 2004; 135 s).

5. Browner WS, Seeley DG, Vogt TV. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 1991; 338: 335-8.

6. Sobchenko KE, Skripnikova IA, Abirova ES, et al. Effect of betaadrenoblockers on the bone mineral density. Osteoporosis and osteopaties 2013; 1: 35-8. Russian (Sobchenko K.E., Skripnikova I.A., Abirova E.S. i dr. Effekt beta-adrenoblokatorov na mineral'nuyu plotnost' kosti. Osteoporoz i osteopatii 2013; 1: 35-8).

7. Toker A, Gulcan E, Toker S. Nebivolol might be beneficial in osteoporosis treatment: hypothesis. Tropical Journal of pharmaceutical research 2009; 8 (2): 181-6.

8. Buvalcev VI, Nebieridze DV, Spasskaya MB. Research of efficiency and safety of a nebivolol at patients with an arterial hypertension in the conditions of polyclinic practice. Cardiovascular Therapy and Prevention 2003; 2(1): 9-16. Russian (Buval'tsev V.I., Nebieridze D.V., Spasskaya M.B. Issledovanie effektivnosti i bezopasnosti nebivolola u bol'nykh arterial'noi gipertoniei v usloviyakh poliklinicheskoi praktiki. Kardiovaskulyarnaya terapiya i profilaktika 2003; 2(1): 9-16.

9. Nazarova AV, Nazarova OA. Parameters of microcirculation and their interrelation with the speed of distribution of a pulse wave at patients with arterial hypertension. Cardiovascular Therapy and Prevention 2014; 13: 80. Russian (Nazarova A.V., Nazarova O.A. Parametry mikrotsirkulyatsii i ikh vzaimosvyaz' so skorost'yu rasprostraneniya pul'sovoi volny u patsientov s gipertonicheskoi bolezn'yu. Kardiovaskulyarnaya terapiya i profilaktika 2014; 13: 80).

10. Kozlov VI. Microcirculation: assessment of a state and diagnostics of frustration of a capillary blood-groove. Angiology and vascular surgery: mater. of the IV Rus. conf. With the international participation “Mikrotsirkulyation in clinical practice” 2012; 8, pril.: 6-7. Russian (Kozlov V.I. Mikrotsirkulyatsiya krovi: otsenka sostoyaniya i diagnostika rasstroistv kapillyarnogo krovotoka. Angiologiya i sosudistaya khirurgiya: mater. IV Vseros konf s mezhdunarodnym uchastiem “Mikrotsirkulyatsiya v klinicheskoi praktike” 2012; 8, pril.: 6-7).

11. Fedorovich AA. Functional condition of regular mechanisms of a microcirculator blood-groove in norm and at arterial hypertension according to a laser Doppler floumentry. Regionarny blood circulation and microcirculation 2010; 1(33): 49-60. Russia. (Fedorovich A.A. Funktsional'noe sostoyanie regulyarnykh mekhanizmov mikrotsirkulyatornogo krovotoka v norme i pri arterial'noi gipertenzii po dannym lazernoi dopplerovskoi floumetrii. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya 2010; 1 (33): 49-60).

12. Kozlov VI, Azishhov GA, Gurova OA, et al. Laser Doppler floumetry in an assessment of a state and frustration of a mikrotsirklyation of blood: a grant for doctors. M., 2012; 32p. Russian (Kozlov V.I., Azishchov G.A., Gurova O.A. i dr. Lazernaya dopplerovskaya floumetriya v otsenke sostoyaniya i rasstroistv mikrotsirklyatsii krovi. Metod posobie dlya vrachei. M., 2012; 32s).

13. Schoofs M, Sturkenboom P, Van Leeuwen J. Use of beta-blockers is associated with BMD and fracture risk. Bone 2005; 36S2: 129-30.

14. Yang S, Nguyen D, Center GR. Assosiation between beta-blockers use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone 2011; 48(3): 451-5.

15. Turker S, Karatosum V, Gunai I. Beta-blockers increase bone mineral dencity. Clin Orthop 2006; 443: 73-4.